These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 17631671)
1. Multivalency - a way to enhance binding avidities and bioactivity - preliminary applications to EPO. Vadas O; Rose K J Pept Sci; 2007 Sep; 13(9):581-7. PubMed ID: 17631671 [TBL] [Abstract][Full Text] [Related]
2. Characterization of new multimeric erythropoietin receptor agonists. Vadas O; Hartley O; Rose K Biopolymers; 2008; 90(4):496-502. PubMed ID: 18273892 [TBL] [Abstract][Full Text] [Related]
4. An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Livnah O; Johnson DL; Stura EA; Farrell FX; Barbone FP; You Y; Liu KD; Goldsmith MA; He W; Krause CD; Pestka S; Jolliffe LK; Wilson IA Nat Struct Biol; 1998 Nov; 5(11):993-1004. PubMed ID: 9808045 [TBL] [Abstract][Full Text] [Related]
6. A high-throughput assay to identify compounds that can induce dimerization of the erythropoietin receptor. Biazzo DE; Motamedi H; Mark DF; Qureshi SA Anal Biochem; 2000 Feb; 278(1):39-45. PubMed ID: 10640351 [TBL] [Abstract][Full Text] [Related]
7. Identification of a 13 amino acid peptide mimetic of erythropoietin and description of amino acids critical for the mimetic activity of EMP1. Johnson DL; Farrell FX; Barbone FP; McMahon FJ; Tullai J; Hoey K; Livnah O; Wrighton NC; Middleton SA; Loughney DA; Stura EA; Dower WJ; Mulcahy LS; Wilson IA; Jolliffe LK Biochemistry; 1998 Mar; 37(11):3699-710. PubMed ID: 9521688 [TBL] [Abstract][Full Text] [Related]
8. Dimerization of the erythropoietin receptor transmembrane domain in micelles. Ebie AZ; Fleming KG J Mol Biol; 2007 Feb; 366(2):517-24. PubMed ID: 17173930 [TBL] [Abstract][Full Text] [Related]
9. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. Middleton SA; Barbone FP; Johnson DL; Thurmond RL; You Y; McMahon FJ; Jin R; Livnah O; Tullai J; Farrell FX; Goldsmith MA; Wilson IA; Jolliffe LK J Biol Chem; 1999 May; 274(20):14163-9. PubMed ID: 10318834 [TBL] [Abstract][Full Text] [Related]
10. [Importance of quality in biotechnology: the case of the first biological similarity of erythropoietin]. Le Cotonnec JY; Lawny F Nephrol Ther; 2009 Feb; 5 Spec No1():10-5. PubMed ID: 19233077 [No Abstract] [Full Text] [Related]
11. A partial model of the erythropoietin receptor complex. Caravella JA; Lyne PD; Richards WG Proteins; 1996 Mar; 24(3):394-401. PubMed ID: 8778787 [TBL] [Abstract][Full Text] [Related]
12. Monitoring ligand modulation of protein-protein interactions by mass spectrometry: estrogen receptor alpha-SRC1. Bovet C; Ruff M; Eiler S; Granger F; Wenzel R; Nazabal A; Moras D; Zenobi R Anal Chem; 2008 Oct; 80(20):7833-9. PubMed ID: 18778086 [TBL] [Abstract][Full Text] [Related]
13. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Xie Z; Wu X; Qiu Q; Gong Y; Song Y; Gu Q; Li C Curr Eye Res; 2007 Sep; 32(9):757-64. PubMed ID: 17882708 [TBL] [Abstract][Full Text] [Related]
14. Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis protein. Kochendoerfer GG; Chen SY; Mao F; Cressman S; Traviglia S; Shao H; Hunter CL; Low DW; Cagle EN; Carnevali M; Gueriguian V; Keogh PJ; Porter H; Stratton SM; Wiedeke MC; Wilken J; Tang J; Levy JJ; Miranda LP; Crnogorac MM; Kalbag S; Botti P; Schindler-Horvat J; Savatski L; Adamson JW; Kung A; Kent SB; Bradburne JA Science; 2003 Feb; 299(5608):884-7. PubMed ID: 12574628 [TBL] [Abstract][Full Text] [Related]
15. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A. Livnah O; Stura EA; Johnson DL; Middleton SA; Mulcahy LS; Wrighton NC; Dower WJ; Jolliffe LK; Wilson IA Science; 1996 Jul; 273(5274):464-71. PubMed ID: 8662530 [TBL] [Abstract][Full Text] [Related]
16. The prolonged half-lives of new erythropoietin derivatives via peptide addition. Lee DE; Son W; Ha BJ; Oh MS; Yoo OJ Biochem Biophys Res Commun; 2006 Jan; 339(1):380-5. PubMed ID: 16314154 [TBL] [Abstract][Full Text] [Related]
17. Hypertension induced by erythropoietin has a correlation with truncated erythropoietin receptor mRNA in endothelial progenitor cells of hemodialysis patients. Ioka T; Tsuruoka S; Ito C; Iwaguro H; Asahara T; Fujimura A; Kusano E Clin Pharmacol Ther; 2009 Aug; 86(2):154-9. PubMed ID: 19458615 [TBL] [Abstract][Full Text] [Related]
18. Improvement of Fc-erythropoietin structure and pharmacokinetics by modification at a disulfide bond. Way JC; Lauder S; Brunkhorst B; Kong SM; Qi A; Webster G; Campbell I; McKenzie S; Lan Y; Marelli B; Nguyen LA; Degon S; Lo KM; Gillies SD Protein Eng Des Sel; 2005 Mar; 18(3):111-8. PubMed ID: 15820978 [TBL] [Abstract][Full Text] [Related]
19. An efficient and versatile synthesis of bisPNA-peptide conjugates based on chemoselective oxime formation. Neuner P; Gallo P; Orsatti L; Fontana L; Monaci P Bioconjug Chem; 2003; 14(2):276-81. PubMed ID: 12643736 [TBL] [Abstract][Full Text] [Related]
20. A transplanted NPVY sequence in the cytosolic domain of the erythropoietin receptor enhances maturation. Nahari T; Barzilay E; Hirschberg K; Neumann D Biochem J; 2008 Mar; 410(2):409-16. PubMed ID: 17995455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]